Bill of Health

NOVEMBER 15, 2023

DEA has done little to reduce the appearance of agency capture by the Opioid Treatment Program (OTP) industry, while FDA was years behind the evidence in approving over-the-counter naloxone.

Governance 173

Governance Public Health Telemedicine COVID-19 173

Healthcare Law Today

NOVEMBER 9, 2022

Starting January 1, 2023, Medicare will cover telehealth-based treatment services delivered by federally-accredited opioid treatment programs (OTPs), commonly referred to as “methadone clinics.” In 2020, CMS established a new Part B benefit category for opioid use disorder (OUD) treatment provided by OTPs.

Medicare 52

Medicare Medicare COVID-19 Telemedicine 52

HIPAA Journal

DECEMBER 22, 2022

billion in funding for the Department of Health and Human Services, increasing HHS funds by a further $9.9 Funding for the Centers for Medicare and Medicaid Services will increase by $100 million, the National Institutes of Health will receive an additional $2.5 The bill proposes $120.7 billion from last year.

FDA 114

FDA COVID-19 Governance Medicaid 114

C&M Health Law

JANUARY 25, 2023

Acute Care Hospital at Home Program and Rural Health Section 4140 of the Act extends the Acute Hospital Care at Home program for two years, through December 31, 2024. These requirements would also apply to state Medicaid fee-for-service programs. The FFCRA authorized increased federal funding to states through a 6.2

Medicaid 104

Medicaid Medicaid Medicare Medicare 104